In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

Last week, STAT’s Anil Oza reported that the Trump administration had targeted a scientific journal for its editorial ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

More than a dozen states are seeking federal permission to add work requirements to their Medicaid programs. Three states — ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

For young people who want to quit vaping, the oral pill varenicline, also known as Chantix, is effective, per a new study.

Last week, at least one scientific journal received a letter from a top U.S. attorney asking it to respond to alleged bias.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

“Trump ’47 should not allow Trump ’45’s massive public health achievement to be cancelled — especially when that legacy will ...

NIH Director Jay Bhattacharya signals that at least one institute director, Nora Volkow at the National Institute on Drug ...

Food companies have voluntarily consented to getting rid of the artificial dyes, Makary said, but there is currently no ...

Last week, AI protein design startup Profluent released a new, more powerful model called ProGen3. The headline takeaway from ...